Gilead Sciences Inc (NASDAQ: GILD)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 12/23/2022
Closing price: 84.75
|Support price level:||$73.03|
|Resistance price level:||N/A|
|Relative strength index (14-day RSI)||33.1|
- The price of this low-beta stock is expected to increase by 0.38% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 6.2% in the next week.
- 13.5% in the next month.
- 42.7% in the next year.
Company news for Gilead Sciences IncGoogle Finance | MarketWatch | WSJ
Analysis for other Health Care stocks